You just read:

Cavendish Leads on the Sale of Off-Patent Branded Pharmaceuticals Provider DB Ashbourne to Top French Pharmaceutial Company Ethypharm

News provided by

Cavendish Corporate Finance

02 Oct, 2015, 07:05 BST